Antimicrobial activity and mechanism of action of Nu-3, a protonated modified nucleotide
Open Access
- 14 January 2011
- journal article
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 10 (1) , 1
Abstract
Background: "Nubiotics" are synthetic oligonucleotides and nucleotides with nuclease-resistant backbones, and are fully protonated for enhanced ability to be taken up by bacterial cells. Nu-3 [butyl-phosphate-5'-thymidine-3'-phosphate-butyl], one of the family members of Nubiotics was efficacious in the treatment of burn-wound infections by Pseudomonas aeruginosa in mice. Subsequent studies revealed that Nu-3 had a favorable toxicological profile for use as a pharmaceutical agent. This study evaluated the antibacterial activity of Nu-3 in vitro and its efficacy as a topical antibiotic. In addition, we investigated the possible mechanisms of Nu-3 action at the levels of DNA synthesis and bacterial membrane changes. Methods: Antimicrobial minimum inhibitory concentrations (MIC) experiments with Nu-3 and controls were measured against a range of Gram-positive and Gram-negative bacteria, including some hospital isolates according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Analysis of the killing kinetics of Nu-3 was also performed against two strains (Staphylococcus aureus cvcc 2248 and Pseudomonas aeruginosa cvcc 5668). The mouse skin suture-wound infection model was used to evaluate the antibacterial activity of Nu-3. We used a 5-Bromo-2'-deoxy-uridine Labeling and Detection Kit III (Roche, Switzerland) to analyze DNA replication in bacteria according to the manufacturer's instruction. The BacLight™ Bacterial Membrane Potential Kit (Invitrogen) was used to measure the bacterial membrane potential in S. aureus. Results: Nu-3 had a wide antibacterial spectrum to Gram-positive, Gram-negative and some resistant bacteria. The MIC values of Nu-3 against all tested MRSA and MSSA were roughly in a same range while MICs of Oxacillin and Vancomycin varied between the bacteria tested. In the mouse model of skin wound infection study, the treatment with 5% Nu-3 glycerine solution also showed comparable therapeutic effects to Ciprofloxacin Hydrochloride Ointment. While Nu-3 had no effect on DNA synthesis of the tested bacteria as demonstrated in a BrdU assay, it could cause bacterial cell membrane depolarization, as measured using a BacLight™ Bacterial Membrane Potential Kit. Conclusions: These results provide additional experimental data that are consistent with the hypothesis that Nu-3 represents a new class of antibacterial agents for treating topical infections and acts via a different mechanism from conventional antibiotics.Keywords
This publication has 18 references indexed in Scilit:
- Acute, Multiple-Dose Dermal and Genetic Toxicity of Nu-3: A Novel Antimicrobial AgentJournal of Biomedicine and Biotechnology, 2010
- Antimicrobials: an endangered species?International Journal of Antimicrobial Agents, 2007
- Antimicrobial resistance in developing countries. Part I: recent trends and current statusThe Lancet Infectious Diseases, 2005
- Antimicrobial resistance in developing countries and responsible risk factorsInternational Journal of Antimicrobial Agents, 2004
- Therapeutic Efficacy of “Nubiotics” against Burn Wound Infection by Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2004
- Skin Microflora and Bacterial Infections of the SkinJournal of Investigative Dermatology Symposium Proceedings, 2001
- The millennium bugs — the need for and development of new antibacterialsInternational Journal of Antimicrobial Agents, 2000
- Antibiotic Resistance: A View from the Pharmaceutical IndustryClinical Infectious Diseases, 1997
- Slow fluorescent indicators of membrane potential: a survey of different approaches to probe response analysisJournal of Photochemistry and Photobiology B: Biology, 1996
- Characterization and Quantitation of Experimental Surgical-Wound Infections Used to Evaluate Topical Antibacterial AgentsAntimicrobial Agents and Chemotherapy, 1976